Type 2 diabetics patients need to be more aware of hypoglycemia signs and risks
Even though hypoglycemia condition is associated with type 1 diabetes (T1D) patient, experts says type 2 diabetes (T2D) patients are also at greater risk for extreme low blood sugar or glucose levels (hypoglycemia condition). The National Institute of Diabetes and Digestive and Kidney Diseases defines hypoglycemia as a condition where blood sugar or glucose levels drop below 70 mg/dL. Following patients with type 2 diabetes are at greater risk for hypoglycemia events.
Patients with type 1 diabetes use a continuous glucose monitoring (CGM) device to prevent hypo (either hypoglycemia or hyperglycemia) events. These hypo events can significantly affect an individual's quality of life, capability to drive safely, daily working and social life. A severe hypo (either hypoglycemia or hyperglycemia) is classified as a medical emergency. The American Diabetes Association (ADA) says hypoglycemia condition causes serious health complications to a patient with diabetes such as life-threatening unconsciousness (diabetic coma), changes in the electrical activity in the brain (seizures) and even death.
A study findings shows failure to detect hypoglycemia events are too often in people with type 2 diabetes. Researchers have an environmental scan on number of articles, clinical guidance documents (20), quality measures (34) and clinician and patient tools (more than 50) to know the frequency of hypoglycemic events and subsequent health outcomes in patients with type 2 diabetes. Researchers have observed following in their analytical study.
In a meta-analysis of patients with type 2 diabetes using insulin drug, researchers have noted 23 modest and one severe hypoglycemia events per year, indicating even patients with type 2 diabetes were affected with hypoglycemia events. Researchers have categorized hypoglycemia events into following categories for the awareness of a patient and healthcare professional to prevent health complications.
Researchers say importance to hypoglycemia events in patients with type 2 diabetes were often underappreciated and not taken care by healthcare professionals. They pay more attention in reducing high blood sugar or glucose levels (or HbA1c) levels in patients with type 2 diabetes and subsequently increasing risk to hypoglycemic events.
Researchers have observed that there are no quality resources to assist healthcare professionals in identifying, assessing and managing patients with diabetes who are at risk to hypoglycemia events. They say following risk assessment tools can help healthcare professionals in addressing hypoglycemia events.
Authors says their study is a first step in establishing more accurate guidelines for the diagnosis and treatment of hypoglycemia events in patients with type 2 diabetes. They also suggest that a patient with type 2 diabetes as well as the healthcare professional treating a patient with type 2 diabetes should know the risks associated with hypoglycemia events and its signs and symptoms.
Lead author of the study was Dr. Robert W. Lash, MD, an endocrinologist, chief professional and clinical affairs officer, Endocrine Society, Washington, DC, United States. The study findings were published 5 March 2018 in the Journal of Clinical Endocrinology & Metabolism. Title of the article was "Preventing Hypoglycemia in Type 2 Diabetes."
10. Devices From Medtronic
11. Devices From Medtronic And Qualcomm
12. Ghrelin Hormone Could Expand Diabetes Treatments And Hypoglycemia
13. Hypoglycemia & HbA1c. Approval Of Diabetes Drug Xultophy Liraglutide From Novo Nordisk
14. Portable Device To Check Diabetes With Exhale Of Acetone Chemical
15. Risks To Severe Hypoglycemia
16. Risks With Hypoglycemia
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.